Aardvark Therapeutics

Privately held: no public share price · United States

Assets

(1 total)
1Total Assets
0Approved
1Phase 3 / Filed
0Phase 1–2 / Early
2Diseases
Quick filter:
Showing 1 of 1 assets
Target & Modality
Phase 3
Bitter taste receptor (gut)Small molecule
ObesityPrader-Willi Syndrome

Upcoming events

No upcoming trial completions or earnings dates on record for this company's assets.

Financial reports

No financial reports recorded.